Quest Diagnostics Completes Acquisition of AmeriPath |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Quest Diagnostics Inc.
One Malcolm Ave.
Teterboro, NJ, 07608
USA
Press release date: May 31, 2007
LYNDHURST, N.J., MAY 31: Quest Diagnostics Incorporated (NYSE:DGX), the leading provider of diagnostic testing, information and services, announced that today it completed its previously announced acquisition of AmeriPath, Inc., a national diagnostic testing company.
"This acquisition creates the world's premier cancer diagnostics company focused on dermatopathology, anatomic pathology and molecular diagnostics," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer of Quest Diagnostics. "This combination will accelerate growth, while providing compelling benefits for patients, physicians, hospitals and payers."
About Quest Diagnostics
Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.questdiagnostics.com.
Source: Quest Diagnostics
CONTACT: media, Nancy Fitzsimmons, +1-201-393-5700, or investors, Laure Park, +1-201-393-5030, both of Quest Diagnostics Web site: http://www.questdiagnostics.com/
|
|
|
|
|
|
|
|
|
|
|
| 
